{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:01:42Z","timestamp":1791291702973,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pcad.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T20:28:23Z","timestamp":1556828903000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Imaging for sudden cardiac death risk stratification: Current perspective and future directions"],"prefix":"10.1016","volume":"62","author":[{"given":"Pieter","family":"van der Bijl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2019.04.005_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2017.03.010","article-title":"Sudden cardiac death: the role of imaging","volume":"237","author":"Van der Bijl","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.recesp.2018.04.040","article-title":"Sudden cardiac death risk prediction: the role of cardiac magnetic resonance imaging","volume":"71","author":"Van der Bijl","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.pcad.2019.04.005_bb0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCEP.110.959544","article-title":"The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators","volume":"4","author":"Scott","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijcard.2014.08.132","article-title":"Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy","volume":"177","author":"Demirel","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2019.04.005_bb0030","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.04.005_bb0035","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","article-title":"Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease","volume":"113","author":"Kwong","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2019.04.005_bb0040","article-title":"Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease","volume":"15","author":"Alexandre","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2019.04.005_bb0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/CIRCIMAGING.113.001293","article-title":"Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction","volume":"7","author":"Watanabe","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCIMAGING.108.826529","article-title":"Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator","volume":"2","author":"Roes","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ehjci\/jew005","article-title":"Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy","volume":"17","author":"Haland","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jmri.25811","article-title":"Increased myocardial native T1 relaxation time in patients with nonischemic dilated cardiomyopathy with complex ventricular arrhythmia","volume":"47","author":"Nakamori","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.pcad.2019.04.005_bb0075","article-title":"Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy","volume":"18","author":"Soslow","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2019.04.005_bb0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.hrthm.2014.12.020","article-title":"Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2019.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.hrthm.2018.05.005","article-title":"Reduced left ventricular mechanical dispersion at 6 months follow-up after cardiac resynchronization therapy is associated with superior long-term outcome","volume":"15","author":"Van der Bijl","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2019.04.005_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.04.005_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"2015","key":"10.1016\/j.pcad.2019.04.005_bb0105","first-page":"36","volume":"2793-2867","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.04.005_bb0110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.hlc.2016.04.007","article-title":"Programmed ventricular stimulation to risk stratify for early cardioverter-defibrillator implantation to prevent tachyarrhythmias following acute myocardial infarction (PROTECT-ICD): trial protocol, background and significance","volume":"25","author":"Zaman","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.pcad.2019.04.005_bb0115","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.04.005_bb0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/CIRCIMAGING.113.000702","article-title":"Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction","volume":"6","author":"Izquierdo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0125","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/ehjci\/jet111","article-title":"Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction","volume":"14","author":"Robbers","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2012.02.070","article-title":"Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation","volume":"60","author":"Klem","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.amjcard.2017.05.019","article-title":"Prevalence, correlates, and prognostic relevance of myocardial mechanical dispersion as assessed by feature-tracking cardiac magnetic resonance after a first ST-segment elevation myocardial infarction","volume":"120","author":"Muser","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jcmg.2013.05.009","article-title":"Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction","volume":"6","author":"Ersboll","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmg.2013.03.005","article-title":"Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction","volume":"6","author":"Haugaa","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.echo.2014.12.012","article-title":"The relationship between time from myocardial infarction, left ventricular dyssynchrony, and the risk for ventricular arrhythmia: speckle-tracking echocardiographic analysis","volume":"28","author":"Leong","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2019.04.005_bb0155","doi-asserted-by":"crossref","unstructured":"Selvanayagam JB, Hartshorne T, Billot L, et al. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol (Epub ahead of print) 2017.","DOI":"10.1111\/anec.12420"},{"key":"10.1016\/j.pcad.2019.04.005_bb0160","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.04.005_bb0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.04.005_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","article-title":"Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure","volume":"7","author":"Masci","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2019.04.005_bb0175","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"Wu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.04.005_bb0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehy713","article-title":"Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults","volume":"40","author":"Shanbhag","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.04.005_bb0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ehjci\/jeu181","article-title":"Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy","volume":"16","author":"Buss","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.echo.2012.02.004","article-title":"Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography","volume":"25","author":"Haugaa","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2019.04.005_bb0200","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/ehjci\/jev333","article-title":"Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy","volume":"17","author":"Negishi","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0205","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2006.094524","article-title":"Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging","volume":"93","author":"Kioka","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2019.04.005_bb0215","doi-asserted-by":"crossref","unstructured":"Tamaki S, Yamada T, Okuyama Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion J Am Coll Cardiol 53:426\u2013435, 2009.","DOI":"10.1016\/j.jacc.2008.10.025"},{"key":"10.1016\/j.pcad.2019.04.005_bb0220","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"issue":"2014","key":"10.1016\/j.pcad.2019.04.005_bb0225","first-page":"35","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"2733-2779","author":"Authors\/Task Force","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.04.005_bb0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0235","unstructured":"Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 58:e212\u2013260, 2011."},{"key":"10.1016\/j.pcad.2019.04.005_bb0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/ejechocard\/jer318","article-title":"Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy","volume":"13","author":"Saito","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0245","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10554-014-0378-z","article-title":"Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients","volume":"30","author":"Debonnaire","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005706","article-title":"Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy","author":"Hiemstra","year":"2017","journal-title":"Circ Cardiovasc Imaging pii"},{"key":"10.1016\/j.pcad.2019.04.005_bb0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic cardiomyopathy registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.04.005_bb0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2019.04.005_bb0265","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0270","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2019.04.005_bb0275","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0280","first-page":"634","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.04.005_bb0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2019.04.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005461","article-title":"Sudden cardiac death substrate imaged by magnetic resonance imaging: from investigational tool to clinical applications","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Imaging pii"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:15:56Z","timestamp":1758500156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062019300751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0033062019300751"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.04.005","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging for sudden cardiac death risk stratification: Current perspective and future directions","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}